US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MRBL Enhanced Equity ETF

46.15

+0.42850.94%

Volume:177.00

Turnover:8.15K

Market Cap:6.46M

PE:- -

High:46.15

Open:46.07

Low:46.07

Close:45.72

52wk High:46.36

52wk Low:31.99

Shares:140.00K

Float Shares:130.00K

Volume Ratio:0.22

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

MRBL Enhanced Equity ETF

Exchange:

CBOE

Establishment Date:

2025

Employees:

- -

Office Location:

3803 West Chester Pike,Newtown Square,Pennsylvania,United States

Website:

http://www.edgetherapeutics.com

Zip Code:

19073

Phone:

Fax:

216 245 3686

Introduction:

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EDGE/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDGE\",,,,,undefined,":{"symbol":"EDGE","market":"US","secType":"STK","nameCN":"MRBL Enhanced Equity ETF","latestPrice":46.152,"timestamp":1770411600000,"preClose":45.7235,"halted":0,"volume":177,"delay":0,"changeRate":0.009371548547245938,"floatShares":130000,"shares":140000,"eps":0,"marketStatus":"Pre-Mkt","change":0.4285,"latestTime":"02-09 06:34:53 EST","open":46.07,"high":46.152,"low":46.07,"amount":8145.921,"amplitude":0.001793,"askPrice":73.84,"askSize":200,"bidPrice":18.47,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770647400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":46.152,"sharesOutstanding":140000,"nav":45.09,"aum":6312600,"bidAskSpread":0,"volumeRatio":0.21696492909016127},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDGE\",,,,,undefined,":{"symbol":"EDGE","floatShares":130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.21696492909016127,"shares":140000,"dividePrice":0,"high":46.152,"amplitude":0.001793,"preClose":45.7235,"low":46.07,"week52Low":31.99,"pbRate":"--","week52High":46.36,"institutionHeld":0,"latestPrice":46.152,"eps":0,"divideRate":0,"volume":177,"delay":0,"ttmEps":0,"open":46.07,"prevYearClose":45.4,"prevWeekClose":46.152,"prevMonthClose":46.0686,"prevQuarterClose":45.4,"fiveDayClose":46.0686,"twentyDayClose":45.855,"sixtyDayClose":43.8154},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDGE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDGE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1902083742,"yearFounded":2025,"address":"3803 West Chester Pike,Newtown Square,Pennsylvania,United States","zipCode":"19073","officePhone":"215 882 9983","officeFax":"216 245 3686"},"stockCompanyDetail":{"websiteUrl":"http://www.edgetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0018},{"period":"1month","weight":0.0065},{"period":"3month","weight":0.0533},{"period":"6month","weight":0.1284},{"period":"1year","weight":0.1433},{"period":"ytd","weight":0.0166}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.","exchange":"CBOE","name":"MRBL Enhanced Equity ETF","nameEN":"MRBL Enhanced Equity ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EDGE\",market:\"US\",,,undefined,":null}}